|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-8-24
|
|
pubmed:abstractText |
The use of left ventricular assist devices is associated with human leukocyte antigen (HLA) allosensitization. We investigated whether prophylactic treatment with low-dose intravenous immunoglobulin (IVIG), analogous to the use of IgG anti-D (anti-Rh) in preventing Rh immunization, can abrogate HLA allosensitization after left ventricular assist device implantation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1552-6259
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
889-93
|
|
pubmed:meshHeading |
pubmed-meshheading:16928502-Adult,
pubmed-meshheading:16928502-Female,
pubmed-meshheading:16928502-Graft Rejection,
pubmed-meshheading:16928502-HLA Antigens,
pubmed-meshheading:16928502-Heart Transplantation,
pubmed-meshheading:16928502-Heart-Assist Devices,
pubmed-meshheading:16928502-Humans,
pubmed-meshheading:16928502-Immunization,
pubmed-meshheading:16928502-Immunoglobulins, Intravenous,
pubmed-meshheading:16928502-Immunosuppressive Agents,
pubmed-meshheading:16928502-Male,
pubmed-meshheading:16928502-Middle Aged,
pubmed-meshheading:16928502-Pulsatile Flow,
pubmed-meshheading:16928502-Retrospective Studies,
pubmed-meshheading:16928502-Surface Properties,
pubmed-meshheading:16928502-Treatment Failure
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
|
|
pubmed:affiliation |
LDS Hospital, University of Utah School of Medicine, Utah Transplantation Affiliated Hospitals Cardiac Transplant Program, Salt Lake City, Utah 84143, USA.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
